Authors: Arango, D Cruts, M Torres, O Backhovens, H Serrano, ML Villareal, E Montanes, P Matallana, D Cano, C Van Broeckhoven, C Jacquier, M

Citation: D. Arango et al., Systematic genetic study of Alzheimer disease in Latin America: Mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia, AM J MED G, 103(2), 2001, pp. 138-143

Authors: Augenlicht, LH Wadler, S Arango, D

Citation: Lh. Augenlicht et al., Clinical response to fluorouracil and p53, N ENG J MED, 345(14), 2001, pp. 1065-1066

Authors: Stanton, MT Ettarh, R Arango, D Tonra, M Brennan, PC

Citation: Mt. Stanton et al., Diagnostic ultrasound induces change within numbers of cryptal mitotic andapoptotic cells in small intestine, LIFE SCI, 68(13), 2001, pp. 1471-1475

Authors: Arango, D Corner, GA Wadler, S Catalano, PJ Augenlicht, LH

Citation: D. Arango et al., c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo, CANCER RES, 61(12), 2001, pp. 4910-4915

Authors: Arango, D Ettarh, RR Brennan, PC

Citation: D. Arango et al., Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: Single and double administration protocols, DIG DIS SCI, 45(12), 2000, pp. 2306-2312

Authors: Arango, D Ettarh, RR Brennan, PC

Citation: D. Arango et al., BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts, SC J GASTR, 34(1), 1999, pp. 68-72